Sponsor or institution
Clinical trials and research at Gateway Bio, INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
POEGMA-based alternative to PEG to improve biotherapeutic delivery
A Phase II SBIR project is testing a PEG-free alternative, POEGMA, to help biotherapeutics stay in the body longer and reduce immune reactions in patients.
-
POEGMA-coated uricase as a PEG-free option for hard-to-treat gout
This project is developing a PEG-free version of the enzyme uricase to help people with severe gout who don't respond to other treatments.
-
Developing a new treatment to improve the effectiveness of gout medication
This study is testing a new type of polymer that could make gout treatments work better and be safer for people who have had allergic reactions to current options, by using a special compound to help a medicine stay effective in the body.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.